T. Rowe Price Associates’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-198,326
| Closed | -$3.44M | – | 2932 |
|
2024
Q1 | $3.44M | Buy |
198,326
+196,126
| +8,915% | +$3.4M | ﹤0.01% | 1335 |
|
2023
Q4 | $29K | Hold |
2,200
| – | – | ﹤0.01% | 2851 |
|
2023
Q3 | $82K | Sell |
2,200
-865
| -28% | -$32.2K | ﹤0.01% | 2692 |
|
2023
Q2 | $124K | Buy |
3,065
+70
| +2% | +$2.83K | ﹤0.01% | 2645 |
|
2023
Q1 | $218K | Sell |
2,995
-258
| -8% | -$18.8K | ﹤0.01% | 2485 |
|
2022
Q4 | $267K | Sell |
3,253
-1,025
| -24% | -$84.1K | ﹤0.01% | 2412 |
|
2022
Q3 | $405K | Buy |
4,278
+2,513
| +142% | +$238K | ﹤0.01% | 2228 |
|
2022
Q2 | $344K | Buy |
1,765
+618
| +54% | +$120K | ﹤0.01% | 2380 |
|
2022
Q1 | $266K | Buy |
1,147
+247
| +27% | +$57.3K | ﹤0.01% | 2589 |
|
2021
Q4 | $355K | Sell |
900
-469
| -34% | -$185K | ﹤0.01% | 2528 |
|
2021
Q3 | $613K | Buy |
1,369
+8
| +0.6% | +$3.58K | ﹤0.01% | 2274 |
|
2021
Q2 | $529K | Buy |
1,361
+195
| +17% | +$75.8K | ﹤0.01% | 2362 |
|
2021
Q1 | $419K | Buy |
1,166
+13
| +1% | +$4.67K | ﹤0.01% | 2441 |
|
2020
Q4 | $566K | Buy |
1,153
+564
| +96% | +$277K | ﹤0.01% | 2188 |
|
2020
Q3 | $191K | Buy |
+589
| New | +$191K | ﹤0.01% | 2428 |
|
2019
Q3 | – | Sell |
-10,609
| Closed | -$5.33M | – | 2511 |
|
2019
Q2 | $5.33M | Sell |
10,609
-59,461
| -85% | -$29.9M | ﹤0.01% | 1385 |
|
2019
Q1 | $69.6M | Sell |
70,070
-943
| -1% | -$937K | 0.01% | 741 |
|
2018
Q4 | $61.7M | Buy |
71,013
+339
| +0.5% | +$294K | 0.01% | 746 |
|
2018
Q3 | $73.1M | Buy |
70,674
+2,170
| +3% | +$2.24M | 0.01% | 773 |
|
2018
Q2 | $62.9M | Buy |
68,504
+786
| +1% | +$722K | 0.01% | 800 |
|
2018
Q1 | $66M | Buy |
+67,718
| New | +$66M | 0.01% | 775 |
|
2016
Q3 | – | Sell |
-1,070
| Closed | -$602K | – | 2529 |
|
2016
Q2 | $602K | Buy |
1,070
+606
| +131% | +$341K | ﹤0.01% | 1893 |
|
2016
Q1 | $221K | Hold |
464
| – | – | ﹤0.01% | 2268 |
|
2015
Q4 | $306K | Sell |
464
-1,152
| -71% | -$760K | ﹤0.01% | 2147 |
|
2015
Q3 | $1.27M | Buy |
+1,616
| New | +$1.27M | ﹤0.01% | 1639 |
|